Ingalls & Snyder LLC Immuno Precise Antibodies Ltd. Transaction History
Ingalls & Snyder LLC
- $2.26 Billion
- Q1 2024
A detailed history of Ingalls & Snyder LLC transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Ingalls & Snyder LLC holds 1,288,535 shares of IPA stock, worth $1.3 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
1,288,535
Previous 1,281,305
0.56%
Holding current value
$1.3 Million
Previous $2.19 Million
10.59%
% of portfolio
0.09%
Previous 0.1%
Shares
14 transactions
Others Institutions Holding IPA
# of Institutions
27Shares Held
1.67MCall Options Held
27.3KPut Options Held
23.2K-
Northern Trust Corp Chicago, IL54KShares$54,4890.0% of portfolio
-
Bank Of Montreal Toronto, A653.8KShares$54,3430.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$41,6120.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny37.6KShares$37,9760.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA33KShares$33,3180.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $25.1M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...